A Phase I Study of the Combination of Panobinostat and Carfilzomib in Patients With Relapsed and/or Refractory Multiple Myeloma
This study is currently recruiting participants.
Verified September 2012 by Emory University
Sponsor:
Emory University
Collaborators:
Multiple Myeloma Research Consortium
Novartis
Onyx Therapeutics, Inc.
Information provided by (Responsible Party):
Jonathan Kaufman, Emory University
ClinicalTrials.gov Identifier:
NCT01549431
First received: March 7, 2012
Last updated: September 12, 2012
Last verified: September 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | January 2015 |
| Estimated Primary Completion Date: | January 2014 (Final data collection date for primary outcome measure) |